Login / Signup

Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes.

Xiaoli WuMingyue LiYanfang ZhangBoyun LiangJunming ShiYaohui FangZhengyuan SuMengmeng LiWenjing ZhangLing XuJun WangQiaoli WuShuang TangHualin WangTao ZhangCheng PengXin ZhengFei DengShu Shen
Published in: Virologica Sinica (2020)
Severe fever with thrombocytopenia syndrome virus (SFTSV), the causative agent of a febrile human disease, was first identified from central and eastern provinces in China, and later in Japan and South Korea. Hubei Province is one of the major SFTS epidemic areas in the central part of China. This study reported the isolation of 11 new SFTSV strains from patients in Hubei Province collected in 2017. Extensive phylogenetic analyses were conducted based on the complete coding sequences of SFTSV segments including the new strains. It was suggested that five different SFTSV genotypes were circulating in Hubei, and 15 reassortment patterns and migration pathways correlated with each genotype were identified, which was more than previously recognized. Hubei Province was more involved in the evolutionary events of SFTSV than that previously thought in which the evolutionary events of SFTSV were reported to be independent from those in other epidemic regions. Further divergence of SFTSV strains was suggested by pairwise comparison of SFTSV sequences from each genotype and sequence identity normalized to representative strain in genotype C1. Subsequently, amino acid variations specific for genotype(s), strain(s), or cluster(s) were inspected, which may be related to differential biological activity of SFTSV strains/genotypes. In conclusion, we analyzed the current status of SFTSV phylogeny in Hubei Province and discussed the possible events correlated to SFTSV evolution. It provided an in-depth insight into SFTSV evolution, raising concerns for the use of proper SFTSV strains in future studies.
Keyphrases
  • escherichia coli
  • south africa
  • current status
  • end stage renal disease
  • chronic kidney disease
  • genome wide
  • newly diagnosed
  • dna methylation
  • ejection fraction
  • clinical evaluation